Location Watertown, Massachusetts, United States Regions Greater Boston Area, East Coast, New England Gender Male
LinkedIn View on LinkedIn
Jim Jenson, PhD is a life-science entrepreneur and executive with 29 years experience in the pharmaceutical and biotechnology industries. He is currently CEO and co-Founder of Sabik Medical Inc., based in Boston. Sabik is a biotech startup developing a new technology for the diagnosis, staging, and treatment of cancer, with an initial focus on
prostate cancer.
Previously, he was CEO and co-Founder of Dicerna Pharmaceuticals, Inc. located in Watertown, Massachusetts. Dicerna is a venture-backed company developing novel therapeutics for multiple indications based on ‘Dicer Substrate’ technology, which makes use of the RNA interference mechanism (RNAi).
Prior to Dicerna, Jim was CEO and co-Founder of Zapaq Inc., which later merged with another company to form CoMentis. The Company’s brain-accessible beta-secretase enzyme inhibitor was licensed to Astellas and is expected to be among the first significantly disease-modifying therapies for Alzheimer’s Disease.
Prior to Zapaq, Jim served in a variety of roles at Procept; Triton/Berlex/Schering A.G.; and Hoffmann-LaRoche. Jim holds a PhD in Biology and Biochemistry from Cornell University and a BA in Biology from Macalester College.
